Above is a chart showing the most common types of anti-depression medications cancer patients in the U.S. are taking while undergoing chemotherapy treatment. Among the roughly one-in-four U.S. cancer patients who take medications for depression during chemotherapy (24 percent), the most common anti-depression medication taken is Sertraline (Zoloft®) (60 percent). Fluoxetine (Prozac®) is taken by 20 percent of U.S. cancer patients in treatment, and another 30 percent say they are taking Citalopram (Celexa®) or Paroxetine (Paxil®) (both 15 percent). A small percentage of U.S. Cancer Patients (15 percent) take either Amitriptyline (Elavil®) or Nortriptyline (Pamelor®) during chemotherapy treatment, and less than 1 percent take Imipramine (Tofranil®).
chemoWave is a FREE mobile health app for cancer patients that empowers them to track symptoms, moods, activities and treatment experiences, scheduling medication reminders, and tracking steps and water intake. chemoWave helps people with cancer propel themselves to learn by generating their own personal, AI-enabled health insights that identify the things that are related to feeling better or worse. chemoWave enables patients fighting cancer to work more effectively with their doctors or support team to better control the side effects and symptoms they experience. chemoWave is available for iPhone and Android.